In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Previews (4/07)

Executive Summary

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: The Good News for Drug Delivery, features profiles of Aequus Biopharma, Macroflux, PharmaKodex, and Supernus. Plus these Start-Ups Across Health Care: Arterial Remodeling Technologies, LifeSync, Marinus Pharmaceuticals, and Tibion.

You may also be interested in...



Arterial Remodeling Technologies

Paris-based Arterial Remodeling Technologies is developing a bioabsorbable stent that may not require the use of anti-inflammatories.

Tibion Corp.

The designs and materials may be more sophisticated, but orthotic devices today play the same role that they always have: to passively stabilize damaged muscles or limbs. Technical advances in software, mechanical and electrical engineering are driving the development of active orthotics--devices that not only support, but also assist and augment muscle strength. Tibion intends to be one of the first to market with wearable, sensor-driven orthotics designed to restore mobility to patients who have lost muscle function due to disease, injury or aging. In addition to improving the quality of life for these patients, its devices can also provide active resistance to strengthen underyling muscle, leading to shorter recovery times and improved outcomes.

LifeSync Corp.

LifeSync is discovering that the introduction of its wireless electrocardiogram (ECG) data communication system, which eliminates the lead wires of traditional ECG systems, while not necessarily enabling remote communications, is bringing clinical and economic advantages to hospitals.

Related Content

Related Companies

UsernamePublicRestriction

Register

IV002934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel